Three Appointed to Health Information and Analysis Oversight Council

BOSTON — Gov. Charlie Baker announced three appointments to the Health Information and Analysis Oversight Council charged with developing the Center for Health Information and Analysis’ (CHIA) research agenda and analytic priorities.

“I’m pleased to appoint three of the brightest minds in healthcare, big data, and financing to positions on the Oversight Council,” Baker said. “I look forward to their ideas for improving the cost-effectiveness and ensuring the long-term sustainability of our healthcare system.”

The three appointees are:

• Fay Donohue, recently retired from her CEO post at oral-health enterprise DSM/Dentaquest, where she developed cost- and quality-focused systems that have won approval for oral-health-plan businesses across the county. She anticipated and filled needs created through state exchanges as part of the U.S. Affordable Care Act, pioneered a cost-effective expansion of oral-health services to underserved populations, and contributed to a quadrupling of plan size in seven years. She serves as a strategic and operations leadership advisor on boards of diverse nonprofit and for-profit organizations, including the National Institute of Children’s Health Care Quality, the Massachusetts Taxpayers Foundation, and the Commonwealth Institute;

• Bill Geary, a partner and co-founder at Flare Capital Partners, a team of healthcare-technology venture-capital investors delivering strategic industry resources and insight to partnering entrepreneurs. Previously, he was with North Bridge Venture Partners. During his 20-year tenure investing in emerging healthcare-technology companies, he has served on the boards of numerous industry-leading companies, actively helping and working closely with management teams. Geary has held previous positions with Hambro International Equity Partners, MathSoft, Congoleum Corp., and Arthur Andersen & Co. He currently serves on the of trustees at Boston College and MGH Institute of Health Professions; and

• Colin Hill, who has served as chairman, CEO, and co-founder of GNS Healthcare Inc. in Cambridge, a nationally recognized innovator in the use of big data to study population health and precision medicine. He is also chairman and co-founder of Via Science, applying machine-learning applications to the ‘Internet of things,’ precision agriculture, and consumer behavior. Previously, he applied this platform to quantitative finance and e-commerce as chairman and co-founder of Fina Technologies. Additionally, he was a founding member of the board of directors of AesRx, a biopharmaceutical company dedicated to the development of new treatment for sickle-cell disease.